FASTinov will be present at the ECCMID congress in Copenhagen, Denmark, on 15-18 April 2023
FASTinov will be present at the upcoming 33nd European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Copenhagen, Denmark on April 15-18.
The company has started the commercialization of its ultra-rapid Antibiotic Susceptibility Testing technology capable of establishing phenotypic susceptibility in less than two hours directly from blood cultures.
“The field of antimicrobial susceptibility testing is experiencing a revolution. Determining phenotypic susceptibility in 2-hours from blood cultures has the potential to change the response to bloodstream infectious. ECCMID is the largest Clinical Microbiology & Infectious Diseases event in the world and the thousands of experts attending come precisely to learn about these technological breakthroughs
FASTinov will be at stand EN-05. Come visit us!
FASTinov has developed ultra-rapid, phenotypic antibiotic susceptibility tests for bloodstream infections that deliver antibiograms in less than 2 hours, based upon patented technologies. The company is based in Porto, Portugal.
For press inquiries, please contact: firstname.lastname@example.org
- For press inquiries, please contact: email@example.com
Share with friends